GeneYouIn is a Canadian personalized medicine company with a suite of products that help healthcare practitioners make better-informed treatment decisions based on an individual’s genetic make-up.
The GeneYouIn vision promotes an optimal balance of clinical utility, patient empowerment, and cost-efficient, targeted genome analysis.
We believe the immediate future will see genetic insights become standard inputs for the optimizing of patients’ health and wellness. We develop applications addressing the needs of both healthcare consumers and front-line care providers. Historically, access to genetic knowledge has been limited, not so much by sequencing costs as by the cost of analysis, interpretation and custom reporting. As a significant step towards automating genome annotation and reporting, we have developed Pillcheck™.
ANTOINE LEFAIVRE – PRESIDENT
Antoine Lefaivre is seasoned executive with background in strategy, business development, and general management. He is an expert alliance builder, deal-maker, and veteran in the pharmaceutical supply chain, healthcare IT, and insurance markets in Canada. Antoine oversaw development of the Health Analytics business at Telus (TOR: CA:T), and helped grow the Health Benefits Management Divisions. He grew various businesses at McKesson Canada, (NYSE:MCK) including its specialty and hospital business, growing volumes from $20M to over $1B. Antoine also led expansion of AmerisourceBergen (NYSE: ABC) in Canada.
RUSLAN DORFMAN, PH.D., MBA – FOUNDER, CSO & CTO
Ruslan Dorfman is a trailblazer in personalized medicine, a molecular geneticist and technology builder. Inspired by direct interactions with Cystic Fibrosis families from all over the world, Dr. Dorfman co-founded GeneYouIn to facilitate access to advanced genetics for the general public. He managed large-scale R&D programs at Sick Kids Hospital, Toronto. Advised Bridgepoint and Mt. Sinai hospitals on implementation of personalized medicine programs. Dr. Dorfman has published thirty peer-reviewed papers on the genetics of Cystic Fibrosis and Pain.
VERONIKA LITINSKI – COO
Veronika Litinski is a company builder, health technology innovator and financier. Her expertise in launching innovative medical sector products, building teams and developing winning commercial alliances, underpin the growth trajectory at GeneYouIn. Veronika piloted the launch and development of Cogniciti (cogniciti.com). Cogniciti’s digital health product suite helps millions of adults with significant memory concerns get earlier assessment, diagnosis and treatment. She was Practice Lead for Health Care and Life Sciences during the initial growth years at MaRS Discovery District (marsdd.com). Veronika managed international Venture Finance Partnerships at GATX Capital in San Francisco (NYSE: GMT) and worked in cancer research at Lawrence Livermore Laboratory in Berkeley.
GOURI MUKERJEE, Ph.D. – SCIENCE OFFICER
Dr. Gouri Mukerjee is a genetics testing expert with vast experience in the field of molecular genetics. She has worked on both basic and applied projects in Tokyo, investigating enzymes & pathways that metabolize xenobiotics, and at Sick Kids Hospital in Toronto. A skilled molecular biologist, she is passionate about utilizing the latest technologies to uncover the biological code that makes us who we are. A firm believer in personalized medicine, she envisions our unique genetic constitutions being routinely used to customize lifestyle advice and medical therapies. She is currently a Scientific Communications Officer for GeneYouIn.
BOYKO KABAKCHIEV, PH.D. – VP BIOINFORMATICS
Boyko has evolved his career from a background in mathematics and biology. He holds a doctoral degree in human genetics and bioinformatics. For a number of years his work has focused on applying cutting edge technology and analytical algorithms to understand the genetic causes of complex disorders of the immune system. His investigations include how these methods are used to improve diagnosis and prognosis for patients. At GeneYouIn Inc, Boyko is dedicated to designing and optimizing the algorithms which transform raw genetic data into the meaningful results that enable accurately personalized medicine. His goal is to deliver the best science in order to facilitate the best health outcomes.
ANDREA HUSTON, M.Sc. – BIOINFORMATICIAN
Andrea completed her graduate work at the University of Toronto, specializing in gene expression analysis. Andrea has since worked with high-throughput genotyping data and has experience utilizing a programming-based approach to analyzing heterogeneous data types.
LIZ GARMAN – PRODUCT MANAGER
Liz brings organizational and project management skills to the GeneYouIn team. Prior to joining GeneYouIn, Liz spent more than 9 years in planning & logistics projects and operations at Intel. She is excited to be part of a team developing and delivering quality personalized medicine for individuals and the healthcare space at large.
YURI KHAZIN – DATABASE MANAGER
Yuri Khazin is a seasoned IT professional with deep expertise in Oracle and Linux technologies. Throughout his long career in IT Yuri constantly updates his knowledge in the very latest technology areas related to databases, security, high availability and virtualization. Yuri publishes several high-ranking technology blogs on Oracle topics.
ANTONIETTA M. CERRONI, Ph.D. – BIOMEDICAL COMMUNICATIONS
Dr. Cerroni is a graduate of the University of Toronto with experience in both academic and start-up business environments. She is an accomplished researcher, published author and instructor, with unique critical thinking, problem-solving, communication and editorial skills. Antonietta brings her skills in biomedical communications, calm manner and sharp eye to Technology and Customer Management teams at GeneYouIn. She assists with development of content and programs for the successful on-boarding of our enterprise customers, including educational, quality and client management programs.
COLIN SHAW — SOFTWARE DEVELOPER
Colin Shaw earned a certificate in Computer Programming Applications from the Ryerson-Chang School of Continuing Education in 2015 and has been building web applications ever since. A maker and a tinkerer, Colin is always looking for ways to leverage technology to create and deploy robust software solutions, turning ideas into reality.
ARTURS KRONENBERGS — IT SYSTEM ADMINISTRATOR
Arturs is an IT System Administrator with University Bachelor Degree in Business Management and College Diploma in Computer Networking and Technical Support. Prior joining IT industry, Arturs spent 4 years working in Diplomatic Corps, which has given him excellent text editing, communication skills and ability to strictly follow organization security policy. Arturs never stops learning and constantly updates his knowledge in IT Operations, Hardware and Security.
DR. MICHELINE PIQUETTE-MILLER — PROFESSOR, LESLIE DAN FACULTY OF PHARMACY, UNIVERSITY OF TORONTO
Dr. Micheline Piquette-Miller is a Professor in Pharmacokinetics at the Leslie Dan Faculty of Pharmacy at the University of Toronto and an Associate Editor of Clinical Pharmacology and Therapeutics. She received a Ph.D. in Pharmacokinetics (U of Alberta) and completed a fellowship in Molecular Pharmacology (UCSF). Her research focuses on understanding the molecular mechanisms responsible for patient variability in drug response and has been the recipient of numerous prestigious national and international research awards. Dr. Piquette-Miller has been teaching fundamental concepts and clinical translation of pharmacokinetics, pharmacogenetics and personalized medicine at the University of Toronto for 15 years. She served as Chair of the Pharmacogenetics and Molecular Pharmacology Section for the American Society of Clinical Pharmacology & Therapeutics from 1999-2005 and is past president of the Canadian Society of Clinical Pharmacology.
SCOTT KAHN — RECENTLY RETIRED CIO OF ILLUMINA
Dr. Scott Khan held the following positions at Illumina: VP Commercial, Enterprise Informatics; CIO and VP Informatics. He also was the Chief Science Officer for Accelrys (BIOVIA). Scott holds a Ph.D. in Theoretical Organic Chemistry from the University of California, Irvine.
MARK FOERSTER — VICE PRESIDENT, GROUP OPERATIONS & CLAIMS AT MUNICH RE CANADA (LIFE)
Mark Foerster has an MBA/HBA from the University of Western Ontario, Richard Ivey School of Business. He currently holds an executive position at Munich Re, one of the world’s leading reinsurance companies with approximately 45,000 employees in over 50 locations around the globe. Mark has served on numerous not-for-profit boards and is currently a director on the Children’s Aid Society of Toronto.
RICHARD LAVOIE — SENIOR HEALTH ECONOMIST, RL ANALYTICS
Richard Lavoie is a senior economist with over 15 years of experience in the healthcare industry. He has led various roles as an expert consultant with pharmaceutical firms, insurers and governments. He conducts projects in pharmacoeconomics, forecasting and market access, and advises insurers and benefit consultants on data analytics and drug plan management optimization. In his roles, he developed the analytical skills and his in-depth understanding of market dynamics to integrate various sources of information and generate the insights needed for decision-making. Richard Lavoie holds a master in applied economics (HEC Montréal).